335 related articles for article (PubMed ID: 21858152)
1. The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
Bonomelli C; Doores KJ; Dunlop DC; Thaney V; Dwek RA; Burton DR; Crispin M; Scanlan CN
PLoS One; 2011; 6(8):e23521. PubMed ID: 21858152
[TBL] [Abstract][Full Text] [Related]
2. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.
Doores KJ; Bonomelli C; Harvey DJ; Vasiljevic S; Dwek RA; Burton DR; Crispin M; Scanlan CN
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13800-5. PubMed ID: 20643940
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.
Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ
J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262.
Kong L; Wilson IA; Kwong PD
Proteins; 2015 Mar; 83(3):590-6. PubMed ID: 25546301
[TBL] [Abstract][Full Text] [Related]
5. Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein.
Behrens AJ; Vasiljevic S; Pritchard LK; Harvey DJ; Andev RS; Krumm SA; Struwe WB; Cupo A; Kumar A; Zitzmann N; Seabright GE; Kramer HB; Spencer DI; Royle L; Lee JH; Klasse PJ; Burton DR; Wilson IA; Ward AB; Sanders RW; Moore JP; Doores KJ; Crispin M
Cell Rep; 2016 Mar; 14(11):2695-706. PubMed ID: 26972002
[TBL] [Abstract][Full Text] [Related]
6. Glycoform analysis of recombinant and human immunodeficiency virus envelope protein gp120 via higher energy collisional dissociation and spectral-aligning strategy.
Yang W; Shah P; Toghi Eshghi S; Yang S; Sun S; Ao M; Rubin A; Jackson JB; Zhang H
Anal Chem; 2014 Jul; 86(14):6959-67. PubMed ID: 24941220
[TBL] [Abstract][Full Text] [Related]
7. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
8. Glycan Profiles of gp120 Protein Vaccines from Four Major HIV-1 Subtypes Produced from Different Host Cell Lines under Non-GMP or GMP Conditions.
Wang S; Voronin Y; Zhao P; Ishihara M; Mehta N; Porterfield M; Chen Y; Bartley C; Hu G; Han D; Wells L; Tiemeyer M; Lu S
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941770
[TBL] [Abstract][Full Text] [Related]
9. Simplified procedure for fractionation and structural characterisation of complex mixtures of N-linked glycans, released from HIV-1 gp120 and other highly glycosylated viral proteins.
Biller M; Bolmstedt A; Hemming A; Olofsson S
J Virol Methods; 1998 Dec; 76(1-2):87-100. PubMed ID: 9923743
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.
Raska M; Takahashi K; Czernekova L; Zachova K; Hall S; Moldoveanu Z; Elliott MC; Wilson L; Brown R; Jancova D; Barnes S; Vrbkova J; Tomana M; Smith PD; Mestecky J; Renfrow MB; Novak J
J Biol Chem; 2010 Jul; 285(27):20860-9. PubMed ID: 20439465
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells.
Zhu X; Borchers C; Bienstock RJ; Tomer KB
Biochemistry; 2000 Sep; 39(37):11194-204. PubMed ID: 10985765
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.
van Montfort T; Eggink D; Boot M; Tuen M; Hioe CE; Berkhout B; Sanders RW
J Immunol; 2011 Nov; 187(9):4676-85. PubMed ID: 21957147
[TBL] [Abstract][Full Text] [Related]
14. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.
Pejchal R; Doores KJ; Walker LM; Khayat R; Huang PS; Wang SK; Stanfield RL; Julien JP; Ramos A; Crispin M; Depetris R; Katpally U; Marozsan A; Cupo A; Maloveste S; Liu Y; McBride R; Ito Y; Sanders RW; Ogohara C; Paulson JC; Feizi T; Scanlan CN; Wong CH; Moore JP; Olson WC; Ward AB; Poignard P; Schief WR; Burton DR; Wilson IA
Science; 2011 Nov; 334(6059):1097-103. PubMed ID: 21998254
[TBL] [Abstract][Full Text] [Related]
15. The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entry.
François KO; Balzarini J
J Biol Chem; 2011 Dec; 286(50):42900-10. PubMed ID: 22006924
[TBL] [Abstract][Full Text] [Related]
16. Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
Pritchard LK; Spencer DI; Royle L; Bonomelli C; Seabright GE; Behrens AJ; Kulp DW; Menis S; Krumm SA; Dunlop DC; Crispin DJ; Bowden TA; Scanlan CN; Ward AB; Schief WR; Doores KJ; Crispin M
Nat Commun; 2015 Jun; 6():7479. PubMed ID: 26105115
[TBL] [Abstract][Full Text] [Related]
17. Characterization of N-Glycan Structures on the Surface of Mature Dengue 2 Virus Derived from Insect Cells.
Lei Y; Yu H; Dong Y; Yang J; Ye W; Wang Y; Chen W; Jia Z; Xu Z; Li Z; Zhang F
PLoS One; 2015; 10(7):e0132122. PubMed ID: 26208004
[TBL] [Abstract][Full Text] [Related]
18. Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission.
Mathys L; Balzarini J
PLoS One; 2015; 10(6):e0130621. PubMed ID: 26121645
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
[TBL] [Abstract][Full Text] [Related]
20. Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate.
Stansell E; Panico M; Canis K; Pang PC; Bouché L; Binet D; O'Connor MJ; Chertova E; Bess J; Lifson JD; Haslam SM; Morris HR; Desrosiers RC; Dell A
PLoS One; 2015; 10(4):e0124784. PubMed ID: 25915761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
